INVESTIGATION ON THE SAFETY OF AMNIOTIC MEMBRANE EXTRACTS IN IMPROVING DIABETIC FOOT ULCERS (PHASE 1 CLINICAL TRIAL STUDY)

Authors

  • Alamouti , Mohammad Azimi Department of Tissue Engineering, School of Advanced Technologies in Medicine, Royan Institute, Tehran, Iran
  • Ebrahimi, Marzieh Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
  • Hajizadeh-Saffar, Ensiyeh Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
  • Jamshidi Makiani, Mahin Firoozgar Clinical Research Development Center (FCRDC), Iran University of Medical Sciences,Tehran Iran
  • Koohkan, Azam Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
  • Mahmoudi, Maliheh Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
  • Momeni, Maryam Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
  • Nouri, Masoumeh 1. Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
  • Shayan, Niloufar Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
  • Soltanolizadeh, Fatemeh Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
Abstract:

Background: For nearly 100 years, amniotic membranes have been used to treat various types of skin wounds. Amniotic extract is one of the derivatives of amniotic membrane that contains all the properties of amniotic membrane. The aim of this study was to evaluate the safety of the amniotic membrane extract in the treatment of diabetic ulcers. Methods: This study was an Open labeled clinical trial without control group. A total of 10 patients with Wagner Grade 2 diabetic foot ulcers were selected in both sexes. The extract was used every 48 hours in the first week and every 72 hours from the second week until the end of the wound treatment. Patients were followed up weekly until wound healing. Results: In this study 80% of patients were men and 20% were women with mean age (56.7 ± 8.7) years. The ulcer duration was 8.9 ± 2.12 weeks. The mean area of ulcers at the time of entry into the wound group ≥ 500 mm2, 977.5 ± 201.9 and in the wound group ≤500 mm2 was 145.6 ± 36.4. At 4 weeks post treatment, the wound healing rate in the wound group was ≤500mm2 ,98.9 ± 2.40 % and in the wound group ≥mm2 500 was 92.1 ± 7.23%. in sixth week of treatment, ulcers were complete closure  in both groups. Conclusion: The results of this study suggest that the use of amniotic extract can be effective in the healing of diabetes foot ulcer without any side effects.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Evaluation of the efficacy of integrative programs in improving diabetic foot ulcers’ outcomes: A cross-sectional study

Background: Treatment of a diabetic foot is a principal step in rehabilitative approaches to the complications of diabetes mellitus. Use of integrative educational courses for diabetic patients is dependent on several factors such as cultural entities of the population, patient perceptions of classes, and their previous trainings about diabetes and related complications. The aim of this study w...

full text

A prospective randomised comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcers

Our purpose was to compare healing characteristics of diabetic foot ulcers treated with dehydrated human amniotic membrane allografts (EpiFix®, MiMedx, Kennesaw, GA) versus standard of care. An IRB-approved, prospective, randomised, single-centre clinical trial was performed. Included were patients with a diabetic foot ulcer of at least 4-week duration without infection having adequate arterial...

full text

Treatment of diabetic foot ulcers with dehydrated amniotic membrane allograft: a prospective case series.

OBJECTIVE A diabetic foot ulcer (DFU) is one of the many potential complications associated with diabetes. If not effectively and rapidly treated, DFUs can result in lower extremity amputations. This prospective case series aimed to assess the effectiveness of a dehydrated amniotic-derived tissue allograft (DAMA), with regards to time to wound closure and total number of applications. METHOD ...

full text

The Effect of Educational Intervention Based on the Pender’s Health Promotion Model on Lifestyle of Patients with Diabetic Foot Ulcers: A Clinical Trial

Introduction: The Pender’s health promotion model is a framework used for determining health-promoting lifestyle behaviors in people with chronic diseases. This study aims to investigate the effect of educational intervention based on the Pender’s health promotion model on the lifestyles of patients with diabetic foot ulcers. Materials and Methods: In this clinical trial conducted in 2019, 74 p...

full text

Neuropathic Diabetic Foot Ulcers

From the Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine (A.J.M.B., L.V.), and the Departments of Dermatology and Cutaneous Surgery (R.S.K.), Epidemiology and Public Health (R.S.K.), and Psychology (L.V.), University of Miami School of Medicine, Miami; the Veterans Affairs Medical Center, Miami (R.S.K.); and the Department of Academic Medicine, Manchester Royal Infir...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 18  issue 3

pages  126- 134

publication date 2019-03

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023